In the UK, sales of nervous system medicine have shown consistent growth. The market is poised to rise from $5.02 billion in 2024 to $5.24 billion in 2028. This steady increase reflects a compound annual growth rate (CAGR) of approximately 1% per year since 2023. Over the last two years, sales have expanded gradually, with values showing a noticeable but modest upward trend.

Future trends to watch for include:

Innovations in pharmaceutical technology potentially driving new product launches.
Increasing prevalence of neurological disorders fueling demand.
Policy changes affecting healthcare and drug pricing influencing market dynamics.